PHARM 1 FINAL (COMPREHENSIVE + WKS 9 & 10) Flashcards
(77 cards)
Differentiate the actions of cardiac glycosides, antianginal drugs, and antidysrhythmic drugs
CARDIAC GLYCOSIDES
dealing with heart failure (HF)
+ Inotrope
Digoxin
Describe the signs and symptoms of digitalis toxicity
Compare the side effects and adverse reactions of nitrates, beta blockers, calcium channel blockers, quinidine, and procainamide
Apply the nursing process, including patient teaching, related to cardiac glycosides, antianginal drugs, and antidysrhythmic drugs
Drugs used to maintain or restore circulation
Anticoagulants: Prevent the formation of clots that inhibit circulation
— Anticoagulant = NO CLOTS
Antiplatelets (antithrombotics): Prevent platelet aggregation
— Antiplatelets = NO congregation
Thrombolytics: Attack and dissolve blood clots that have already formed
— Thrombolytics = CUT IT…DISSOLVE IT…the blood clots already formed
Thrombus formation
Pathophysiology
— Formation of clot in artery or vein
— Caused by decreased circulation, platelet aggregation on vessel wall, blood coagulation
Arterial vs. Venous clot formation
Arterial clot formation
— Platelets initiate process.
— Fibrin formation occurs.
— RBCs are trapped in fibrin mesh.
Venous clot formation
— Platelet aggregation with fibrin that attaches to RBCs
Action of the parenteral anticoagulant Heparin
Heparin
Step I: (binds with) Antithrombin III
Step II: (inactivates) Thrombin
Step III (inhibits conversion of) Fibrinogen ==> Decr. Fibrin
Step IV: Clot prevented
HEPARIN
Medications: low-molecular-weight heparin (LMWH): enoxaparin sodium (Lovenox), dalteparin sodium (Fragmin), and tinzaparin sodium (Innohep)
Contraindications:
— Stroke, peptic ulcer, blood anomalies
— Patients having eye, brain, or spinal surgery
Administration of heparins
— Heparin = usually given subq for prophylaxis and IV for therapeutic anticoagulation
— Lovenox = subQ only
_________________________________
NOTE: As with unfractionated heparin, severe neurologic injury can occur if Lovenox is used in patients undergoing spinal puncture or spinal/epidural anesthesia.
Thrombin = creating a clot b/c last clotting factor needed to convert fibrinogen ==> fibrin ==> foundation for clotting
WARFARIN
Compare the action for anticoagulants, antiplatelets, and thrombolytics
Anticoagulants: prevent the formation of clots that inhibit circulation
Antiplatelets (antithrombotics): prevent platelet aggregation
Thrombolytics: attack and dissolve blood clots that have already formed
Differentiate the side effects and adverse reactions of anticoagulants, antiplatelets, and thrombolytic
Apply the nursing processes, including patient teaching, for anticoagulants and thrombolytics
Describe the action of the two main drug groups: antihyperlipidemics and peripheral vasodilators
Compare the side effects and adverse reactions of antihyperlipidemics
Differentiate the side effects and adverse reactions of peripheral vasodilators
Differentiate the side effects and adverse reactions of peripheral vasodilators
Apply the nursing process, including patient teaching, for antihyperlipidemics and peripheral vasodilators
Cholinergic drugs
Peripheral Nervous System
– Muscarnic agonists
Bethanechol (Urecholine)
PNS: Cholinergic drug
Muscarinic antagonists (anticholinergics)
– Atropine
–Scopolamine
Cholinesterase inhibitors
–Neostigmine (Prostigmine) AND Edrophonium (Tensiolon) = MG when peripherally acting
– Rivastigmine (Exelon) = for AD when centrally acting
Neuromuscular blockers
Succinycholine
Dantrolene = acts in CNS as muscle relaxant, but also used to tx malignant hyperthermia + neuroleptic malignant syndrome